KR840006767A - 항진균성 겔 조성물 - Google Patents

항진균성 겔 조성물 Download PDF

Info

Publication number
KR840006767A
KR840006767A KR1019830005598A KR830005598A KR840006767A KR 840006767 A KR840006767 A KR 840006767A KR 1019830005598 A KR1019830005598 A KR 1019830005598A KR 830005598 A KR830005598 A KR 830005598A KR 840006767 A KR840006767 A KR 840006767A
Authority
KR
South Korea
Prior art keywords
gel composition
antifungal
composition according
gel
dispersant
Prior art date
Application number
KR1019830005598A
Other languages
English (en)
Inventor
폰 비테라 미클러즈 (외 4)
Original Assignee
에리히 데브릿쯔, 게르하르드 뷔네만
바이엘 아크티엔 게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에리히 데브릿쯔, 게르하르드 뷔네만, 바이엘 아크티엔 게젤샤프트 filed Critical 에리히 데브릿쯔, 게르하르드 뷔네만
Publication of KR840006767A publication Critical patent/KR840006767A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Abstract

내용 없음

Description

항진균성 겔 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 벤질알코올 1 내지 5%, 분산제 2.5 내지 35% 및 겔-형성제로서, a) 약 30몰의 에텔렌옥사이드를 함유한 세틸스테알릴 알코올 10 내지 30% 또는 b) 폴리아크릴산, 폴리메타아크릴산 및/또는 염 1 내지 5%를 함유함을 특징으로 하는, 아졸유도체와 통상적인 제형보조제를 함유하며 유효화합물의 방출을 증진시키는 항진균성 겔 조성물.
  2. 제1항에 있어서, 유효화합물로서 하기 구조식의 클로트리마졸을 함유함을 특징으로 하는 항진균성 겔 조성물.
  3. 제1항에 있어서, 유효화합물로 하기 구조식의 비포나졸을 함유함을 특징으로 하는 항진균성겔 조성물.
  4. 제1항에 있어서, 유효화합물로서 하기구조식의 롬바졸을 함유함을 특징으로하는 항진균성 겔 조성물.
  5. 제1항에 있어서, 항진균성 아졸유도체를 0.05내지 1%(0.1 내지 1%가 바람직하다)함유함을 특징으로 하는 항진균성 겔 조성물.
  6. 한 종류이상의 아졸유도체, 벤질알코올 1 내지 5%, 분산제 2.5내지 35% 및 겔-형성제로서, a)약 30몰의 에틸렌옥사이드를 함유한 세틸스테아릴 알코올 10내지 30% 또는 b)폴리아크릴산, 폴리메타아트릴산 및/또는 염 1내지 5%로 이루어진 혼합물을 질소대기하에 110℃에서 용해시킨 후, 수상과 혼합한 다음, 서서히 교반하면서 25℃로 냉각시킴을 특징으로 하여, 벤질알코올 1내지 5%, 분산제 2.5내지 35%, 및 겔-형성제로서, a) 약 30몰의 에틸렌옥사이드를 함유한 세틸스테아릴알코올 10내지 30% 또는 b)폴리아크릴산, 폴리메타아크릴산 및/또는 염 1 내지 5%를 함유하고, 이졸유도체와 통상적인 제형보조제를 함유하며, 유효화합물의 방출을 증진시키는 항진균성 겔 조성물을 제조하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019830005598A 1982-11-27 1983-11-26 항진균성 겔 조성물 KR840006767A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823244027 DE3244027A1 (de) 1982-11-27 1982-11-27 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von gelsystemen
DEP3244027.8 1982-11-27

Publications (1)

Publication Number Publication Date
KR840006767A true KR840006767A (ko) 1984-12-03

Family

ID=6179276

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830005598A KR840006767A (ko) 1982-11-27 1983-11-26 항진균성 겔 조성물

Country Status (11)

Country Link
EP (1) EP0113009A3 (ko)
JP (1) JPS59108713A (ko)
KR (1) KR840006767A (ko)
AR (1) AR231397A1 (ko)
CA (1) CA1209916A (ko)
DE (1) DE3244027A1 (ko)
DK (1) DK541783A (ko)
ES (1) ES8406192A1 (ko)
HU (1) HU187612B (ko)
IL (1) IL70320A0 (ko)
NO (1) NO834083L (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61151117A (ja) * 1984-12-25 1986-07-09 Bayer Yakuhin Kk 抗真菌ゲル製剤
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
JPH01246219A (ja) * 1988-03-25 1989-10-02 Nippon Nohyaku Co Ltd 抗真菌外用クリーム組成物
JPH01242525A (ja) * 1988-03-25 1989-09-27 Nippon Nohyaku Co Ltd 抗真菌外用剤
DE4234188C2 (de) * 1992-10-10 1996-01-11 Beiersdorf Ag Antimycotische kosmetische und dermatologische Verwendungen
IT1284874B1 (it) 1996-08-02 1998-05-22 Farmigea Spa Complessi bioadesivi di polycarbophil e farmaci antifungini o antiprotozoari azolici

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52117416A (en) * 1976-03-29 1977-10-01 Nippon Kayaku Co Ltd Novel ointment base
JPS5562008A (en) * 1978-10-31 1980-05-10 Sumitomo Chem Co Ltd Preparation of cream
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften
JPS5815909A (ja) * 1981-07-22 1983-01-29 Toko Yakuhin Kogyo Kk 抗真菌外用剤

Also Published As

Publication number Publication date
DE3244027A1 (de) 1984-05-30
DK541783A (da) 1984-05-28
NO834083L (no) 1984-05-28
EP0113009A2 (de) 1984-07-11
ES527566A0 (es) 1984-08-01
JPS59108713A (ja) 1984-06-23
AR231397A1 (es) 1984-11-30
DK541783D0 (da) 1983-11-25
EP0113009A3 (de) 1985-09-25
ES8406192A1 (es) 1984-08-01
HU187612B (en) 1986-02-28
IL70320A0 (en) 1984-02-29
CA1209916A (en) 1986-08-19

Similar Documents

Publication Publication Date Title
KR840005083A (ko) 항고혈압제로서 유용한 아미노산유도체의 제조방법
KR840000528A (ko) 비스-트리아졸 유도체의 제조방법
SE7406513L (sv) Gastrinsyrasekretionsmedel.
KR840000236A (ko) 포유류의 국부용 제형의 수분 손실량을 극소화시키는 방법
KR850000239A (ko) 소립자의 제조와 캡슐화방법
SE8204237L (sv) Karbostyrilforeningar, kompositioner innehallande dessa samt forfaranden for framstellning derav
HU171226B (hu) Insekticidnye, akaricidnye i fungicidnye kompozicii, i sposob poluchenija proizvodnykh amidokarbonil-tiobarbiturovojj kisloty i soli primenimykh aktivnymi agentami
KR840006767A (ko) 항진균성 겔 조성물
ES306608A1 (es) Procedimiento para la preparacion de productos contra la fragilidad de las unas
US4128632A (en) Solubilization of Rafoxanide
ES450075A1 (es) Un metodo de preparacion de derivados de bis-triazinilamino-estilbeno.
IE45516L (en) 2-(4'-thiazolyl) benzimidazole complex
ES414952A1 (es) Procedimiento para la preparacion de 4-(4-bifenilil)-buta- noles.
KR840006766A (ko) 항 진균제의 제조방법
KR900016156A (ko) 퀴녹살린 유도체 및 궤양치료제
KR880012635A (ko) 신규 2β , 16β-디아미노-안드로스탄
KR890012960A (ko) 결정성 β-락탐 용매화물
KR850000405A (ko) 항진균제의 제조방법
GB1354263A (en) Therapeutic composition
GB1002182A (en) Fungicidal preparations
JPS54112864A (en) Novel imidazole derivative, its mineral acid salt, and their preparation
NL7502535A (nl) Werkwijze ter bereiding van 1,3-dicarbonylver- bindingen alsmede van medicinale en andere pre- paraten die deze verbinding als aktieve compo- nent omvatten.
GB894619A (en) Stabilized liquid preparations comprising tetracycline antibiotics
KR880012645A (ko) 항-진균활성도를 가지는 β-시클로 덱스트린 착염
EP0008950A3 (en) Pyrimido(1,6-a)indole derivatives and intermediates therefor, processes for their preparation, pharmaceutical compositions containing the derivatives and their use

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid